Banner Image Forensic

Banner Image Forensic

Aix-en-Provence Convention Centre, Aix-en-Provence, France | May 18-21

SFTA Conference 2026

Join Bruker at SFTA 2026 and learn more about our mass spectrometry-based solutions for forensic analysis.

Conference Page

Welcome to SFTA 2026

We look forward to welcoming you at the 2026 Annual Meeting of the French Society of Analytical Toxicology (Société Française de Toxicologie Analytique, SFTA), taking place from May 18 - 21 at the Aix‑en‑Provence Convention Centre in Aix‑en‑Provence, France. This year’s congress brings together experts, researchers, and industry partners to exchange insights and discuss the latest developments in analytical toxicology.

What to expect:

See the EVOQ DART-TQ⁺ in action and explore chromatography-free mass spectrometry, along with advances in sample preparation, data acquisition performance, and analysis.
Discover chromatography-free workflows using the integrated DART source of the EVOQ DART-TQ⁺ instrument, transforming conventional analyses into ultrafast, robust and cost-saving workflows.
Add the 4^th dimension of ion mobility to HRMS for the highest confidence in NPS identification.
Reliable forensics screening in biological samples with minimum effort using the Drug Screen Suite solution.
Easy-to-use and high sample throughput solution for seized-drug analysis using the Seized Drug Suite.
Ready-to-use kits: ToxBox^® by Pinpoint Testing and ClinMass^® & ClinDART^® by RECIPE Chemicals + Instruments GmbH

Stop by our booth to connect with Bruker experts, discuss your analytical challenges, and explore solutions tailored to your laboratory needs.

We look forward to meeting you in Aix‑en‑Provence and discussing how our products and services can support your analytical and forensic toxicology workflows.

You can also follow us on LinkedIn for the latest updates and more information on our solutions.

May 18 - 21, 2026

Aix-en-Provence Convention Centre, Aix-en-Provence, France

SFTA Conference Page

Highlights

Quantitative Screening of Synthetic Cannabinoids

Rapid and Dynamic Quantitative Screening of Synthetic Cannabinoids with DART-MS Analysis: A Collaborative Case Study

Watch On-Demand

Drug Screen Suite – Confidently and Rapidly Screen for Unknown Drugs: Post-Mortem Casework

The Drug Screen Suite was evaluated for forensic toxicology screening of complex post‑mortem samples. The automated system combines retention time, exact mass, and high‑resolution MS/MS for reliable compound identification and demonstrated robust, sensitive, and specific performance comparable to conventional methods, even in challenging matrices.

Download App Note

Oral Fluid Screening & Confirmation on EVOQ^® DART-TQ⁺

The Bruker EVOQ® DART-TQ+ integrates two independent ionization sources – Direct Analysis in Real Time (DART) for rapid, chromatography-free screening and Vacuum Insulated Probe-Heated Electrospray Ionization (VIP-HESI) for precise LC-MS/MS confirmation – on a single triple quadrupole mass spectrometer.

Download Cae Study

DART-HRMS for the rapid screening of seized drugs: A study on authentic paper samples

Increased backlogs of seized drug samples, long turnaround times and the appearance of a high number of NPS are key challenges within the forensic community worldwide. This application note showcases a comprehensive workflow featuring DART-HRMS, specifically tailored to address these challenges.

Screening of Drug Paraphernalia with the Seized Drug Suite

The Seized Drug Suite is a ready-to-use solution of hardware, software and curated methods designed for fast and reliable seized drug analysis. Using chromatography-free Direct Analysis in Real Time (DART) combined with high-resolution QTOF mass spectrometry data-dependent MS/MS acquisition and spectral library search, the Seized Drug suite enables seamless and seconds-fast detection of substances of abuse.

Download App Note

Bruker tackles drugs of abuse and POPs issues

Are you curious about the latest advancements in drug screening, sustainable analytical methods, and high-resolution screening? Jeffrey Zonderman talked to SelectScience® and shared insights on solutions for drugs of abuse screening and POPs analysis, greener and more efficient alternatives to chromatographic methods and untargeted High-Resolution screening.

Watch Interview

Featured Instruments & Solutions

EVOQ^®DART-TQ⁺

The EVOQ^®DART-TQ⁺ system delivers exceptional speed and sensitivity to set a new benchmark in multiresidue screening and quantitation. Achieve the increased throughput, lower cost of operation, and reduced downtime of chromatography-free workflow screens and confirm with LC-MS for the ultimate confidence in your results.

DART-MS

Direct Analysis in Real Time is a rapid and efficient ionization for mass spectrometry for measuring a wide range of analytes - solids, liquid and gases - in their native form, including many that don’t ionize well with other methods. Add it to an existing mass spectrometry system to ramp up versatility and throughput or invest in a fully integrated DART-MS solution.

impact II VIP

The impact II VIP sets a technology standard for analytical performance in residue and contamination screening, forensics, industrial and synthetic chemistry, biomarker research, and more, with unparalled ultra-high resolution Qq-Time-Of-Flight mass spectrometry.

timsMetabo™

timsMetabo™ is the next-generation research engine for 4D-Metabolomics™ and 4D-Lipidomics™ delivers unprecedented sensitivity, separation power and annotation confidence for small molecules.

Imaging Landing Page Web Header 1920x945

Forensic Toxicology Content Collection

This content collection highlights Bruker’s ready‑to‑use workflows for seized drug analysis and toxicology screening, showing how high‑resolution mass spectrometry and smart automation help labs work faster, reduce complexity, and deliver reliable results.

For Research Use Only. Not for use in clinical diagnostic procedures.